Baader Bank AG

EQS-News: Baader Helvea Swiss Equities Conference sees a large attendance on its return to being a physical event

Retrieved on: 
Thursday, February 2, 2023

Following two years of being held virtually due to the Corona pandemic, the three-day Baader Helvea Swiss Equities Conference took place again this January in Bad Ragaz, Switzerland.

Key Points: 
  • Following two years of being held virtually due to the Corona pandemic, the three-day Baader Helvea Swiss Equities Conference took place again this January in Bad Ragaz, Switzerland.
  • Almost half of the companies listed in the Swiss Market Index were amongst the companies which presented at the event.
  • "The Baader Helvea Swiss Equites Conference in Bad Ragaz has established itself as an important event in Sika's agenda.
  • "The Baader Helvea Swiss Equities Conference was, once again, a great event with many good conversations and a professional organization.

Stifel initiates research coverage of Xlife Sciences

Retrieved on: 
Thursday, February 2, 2023

The renowned investment bank Stifel commenced its research coverage of Xife Sciences (SIX: XLS).

Key Points: 
  • The renowned investment bank Stifel commenced its research coverage of Xife Sciences (SIX: XLS).
  • The corresponding initial analyst report rates Xlife Sciences' stock with a “Buy” rating and calls for a price target of CHF 68.00.-
    Stifel’s initiation report emphasizes that Xlife Sciences provides investors access to early-stage life science research projects from universities and other institutions.
  • At www.xlifesciences.ch/en/news-and-key-figures, a summary of Stifel’s first analyst report on Xlife Sciences can be viewed and downloaded.
  • After Intron Health and Baader Bank, Stifel is the third financial services firm having initiated independent research coverage of Xlife Sciences.

EQS-News: Wyden: Smartbroker Connects With Wyden’s Crypto Asset Trading Platform

Retrieved on: 
Thursday, February 2, 2023

As part of the relaunch of its next generation broker, Smartbroker Holding AG cooperates with Baader Bank and Wyden

Key Points: 
  • As part of the relaunch of its next generation broker, Smartbroker Holding AG cooperates with Baader Bank and Wyden
    Zurich (CH), 23 January 2023 – Wyden, the global leader in institutional digital asset trading technology, will in the future serve as the infrastructure backbone for crypto trading of German neobroker Smartbroker.
  • The basis for this is the partnership entered into in the summer of 2022 with Baader Bank, which will handle securities settlement for Smartbroker.
  • As part of a relaunch of Smartbroker, Wyden will enable Smartbroker customers to trade over 20 cryptocurrencies at discount conditions for the first time via the firm’s digital asset order and execution management (OEMS) platform.
  • Our trading and orchestration platform sets a new benchmark in transparency and security at banking level here, which will increase acceptance and trust in the still young asset class of crypto assets."

EQS-News: beaconsmind AG: Research update by Hauck & Aufhäuser Lampe Privatbank AG confirms “Buy” with a target price of EUR 30.00

Retrieved on: 
Sunday, January 22, 2023

Zurich, Switzerland – 19 December 2022 – Hauck & Aufhäuser Lampe Privatbank AG has published a new study about beaconsmind AG (ISIN: CH0451123589 – Ticker: MLBMD), a leading SaaS provider in the field of location-based marketing (LBM) & analytics.

Key Points: 
  • Zurich, Switzerland – 19 December 2022 – Hauck & Aufhäuser Lampe Privatbank AG has published a new study about beaconsmind AG (ISIN: CH0451123589 – Ticker: MLBMD), a leading SaaS provider in the field of location-based marketing (LBM) & analytics.
  • Hauck & Aufhäuser Lampe Privatbank AG thus currently sees a very clear share price potential of over 150 percent.
  • The new study by Hauck & Aufhäuser Lampe Privatbank AG is available for download on the corporate website of beaconsmind www.beaconsmind.com in the "Investor Relations" section.
  • The current studies on beaconsmind by the research houses Baader Bank AG, First Berlin Equity Research GmbH and Quirin Privatbank AG are also available there.

EQS-News: Smartbroker Holding AG substantiates plans for the relaunch of its Next Generation Broker

Retrieved on: 
Sunday, December 18, 2022

Low-fee trading of more than 20 cryptocurrencies & additional securities account classes (business, junior and joint custody accounts) to be added soon

Key Points: 
  • Low-fee trading of more than 20 cryptocurrencies & additional securities account classes (business, junior and joint custody accounts) to be added soon
    Under the project name "Smartbroker 2.0", the Smartbroker Group is working on the relaunch of its next generation broker.
  • In order to complete the development work, management plans to make further investments of approximately €5 million.
  • Smartbroker customers will benefit from low-cost access to more than 20 cryptocurrencies following the relaunch.
  • Oliver Riedel, Board Member at Baader Bank AG: "We are very much looking forward to working with Smartbroker, the multiple award-winning online broker.

EQS-News: beaconsmind AG: First Berlin Equity Research GmbH starts coverage of the beaconsmind share with a Buy recommendation – target price EUR 22.00

Retrieved on: 
Tuesday, November 29, 2022

First Berlin thus sees a high share price potential of around 82 percent.

Key Points: 
  • First Berlin thus sees a high share price potential of around 82 percent.
  • The closing price of the beaconsmind share was EUR 12.10 (XETRA) on 28 November 2022.
  • The current study on beaconsmind by First Berlin Equity Research GmbH is available for download on beaconsmind's corporate website www.beaconsmind.com in the "Investor Relations" section.
  • beaconsmind is currently accompanied by a total of four research houses, which unanimously recommend the beaconsmind share as a Buy.

EQS-News: Baader Bank reports further growth in nine-month period and slightly positive earnings in the third quarter

Retrieved on: 
Friday, October 28, 2022

Net commission income for the nine-month period was EUR12.1million, up 14% compared to the same period of the previous year (9M2021: EUR10.6million) despite a competitive market.

Key Points: 
  • Net commission income for the nine-month period was EUR12.1million, up 14% compared to the same period of the previous year (9M2021: EUR10.6million) despite a competitive market.
  • The Group's net trading result for the reporting period was EUR90.1million, a decrease of around 39% compared to the same period of the exceptional previous year (9M2021: EUR147.1million).
  • In keeping with this result, the allocation to the fund for general banking risks amounts to EUR9.0million (9M2021: EUR18.4million).
  • The positive contributions to earnings made by the three subsidiaries of BaaderBankGroup the Swiss BaaderHelveaGroup, Baader&HeinsCapitalManagementAG and the SelanGroup all contributed to the Group's nine-month result.

Baader Bank initiates research coverage on Xlife Sciences

Retrieved on: 
Thursday, September 15, 2022

Baader Bank, one of the leading European partners for investment and banking services, has initiated its research coverage on Xlife Sciences (SIX: XLS).

Key Points: 
  • Baader Bank, one of the leading European partners for investment and banking services, has initiated its research coverage on Xlife Sciences (SIX: XLS).
  • The report confirms Xlife Sciences' position as an emerging life sciences incubator, offering investors an attractive opportunity to invest in a number of promising and diverse life sciences projects under one umbrella.
  • An excerpt of Baader Banks analyst report can be viewed and downloaded on Xlife Sciences website at https://www.xlifesciences.ch/en/news-and-key-figures.
  • Oliver R. Baumann, CEO of Xlife Sciences, commented: We are pleased about the research coverage of Xlife Sciences AG by Baader Bank.

DGAP-News: Heidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure

Retrieved on: 
Tuesday, August 30, 2022

Ladenburg, Germany, 30 August 2022 Heidelberg Pharma AG (FSE: HPHA) today successfully completed the capital measure adopted on 12 August 2022 and generates gross issue proceeds of approximately EUR80million by placing all new shares.

Key Points: 
  • Ladenburg, Germany, 30 August 2022 Heidelberg Pharma AG (FSE: HPHA) today successfully completed the capital measure adopted on 12 August 2022 and generates gross issue proceeds of approximately EUR80million by placing all new shares.
  • As part of the capital measure, a total of 12,408,648 new shares at a price of EUR 6.44 each were placed.
  • With the subscription of a total of 11,838,652 shares, Huadong Investment now holds 25% of Heidelberg Pharma shares.
  • Heidelberg Pharma has thus almost completely utilized the Authorized Capital 2020/I available for the issuance of new shares.